Completed NA INTERVENTIONAL 2-arm NCT02294188

Spatial Repellent Products for Control of Vector Borne Diseases - Malaria - Indonesia (SR-M-IDR)

Sponsor: Indonesia-MoH

Conditions Malaria

Interventions Active ingredient Spatial Repellent product with active ingredient (SHIELD) Spatial Repellent product without active ingredient (SHIELD)

Updated 5 times since 2017 Last updated: May 2, 2018 Started: May 31, 2015 Primary completion: Apr 15, 2018 Completion: Apr 15, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Malaria, this trial is completed. The trial is conducted by Indonesia-MoH and has accumulated 5 data snapshots since 2015. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Jan 2017 — Jun 2018 [monthly]

Active Not Recruiting NA

First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Indonesia-MoH
University of Notre Dame

Data source: University of Notre Dame

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jakarta, Indonesia